Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
The Alzheimer's drug LEQEMBI is seen in this undated handout image obtained on January 20, 2023. Eisai/Handout via REUTERS /File Photo Acquire Licensing Rights TOKYO, Sept 25 (Reuters) - Japan's Eisai (4523.T) said on Monday its Alzheimer's treatment developed with Biogen (BIIB.O), Leqembi, was…
#eisai #biogen #leqembi #fda #medicare #biogenjapan